Iovino Claudio, Rosolia Andrea, Marano Ernesto, Della Corte Michele, Testa Francesco, Simonelli Francesca
Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
Am J Ophthalmol Case Rep. 2023 Dec 28;33:101981. doi: 10.1016/j.ajoc.2023.101981. eCollection 2024 Mar.
To report the efficacy and safety of navigated 577nm yellow subthreshold micropulse laser (YSML) treatment in a case of refractory cystoid macular edema (CME) following combined phaco-vitrectomy for rhegmatogenous retinal detachment (RRD).
A 69-year-old male patient complained a slow and progressive visual loss in the right eye (RE) since two months. A complete ophthalmological evaluation was performed. Best corrected visual acuity (BCVA) was hand motion and slit lamp examination revealed a nuclear cataract and a total macula-off RRD in the RE. Patient underwent a combined phaco +25 gauge pars plana vitrectomy (PPV) with 5000 cSt silicon oil (SO) tamponade. At the 3-month follow up BCVA was 20/250, retina was completely flat but a macular proliferative vitreoretinopathy (PVR) was detected with swept source optical coherence tomography (SS-OCT) and a second 23 G PPV with PVR peeling and SO removal was performed. At 1 month visit from the second surgery retina was flat and BCVA was 20/200 due to a persistent CME. Oral carbonic anhydrase inhibitors and topical steroids were administered for 2 months without any improvements. At this point, YSML was applied with a macular grid pattern and at three months follow up visit SS-OCT showed a complete resolution of CME, BCVA was 20/100 and these anatomical and functional outcomes were maintained at 6 months follow-up.
YSML treatment may be considered a safe and effective treatment strategy for the management of refractory CME following complex RRD surgery cases.
报告导航577纳米黄色阈下微脉冲激光(YSML)治疗一例孔源性视网膜脱离(RRD)联合白内障超声乳化玻璃体切除术后难治性黄斑囊样水肿(CME)的疗效和安全性。
一名69岁男性患者自两个月前起右眼视力逐渐缓慢下降。进行了全面的眼科评估。最佳矫正视力(BCVA)为手动,裂隙灯检查显示右眼有核性白内障和完全黄斑脱离的RRD。患者接受了联合白内障超声乳化 + 25G玻璃体切除术(PPV),并使用5000厘沲硅油(SO)填充。在3个月随访时,BCVA为20/250,视网膜完全平复,但扫频光学相干断层扫描(SS - OCT)检测到黄斑增殖性玻璃体视网膜病变(PVR),遂进行了第二次23G PPV,行PVR剥除及SO取出术。第二次手术后1个月复查,视网膜平复,因持续性CME,BCVA为20/200。口服碳酸酐酶抑制剂和局部应用类固醇治疗2个月,病情无改善。此时,采用黄斑格栅模式应用YSML,3个月随访时SS - OCT显示CME完全消退,BCVA为20/100,这些解剖和功能结果在6个月随访时得以维持。
对于复杂RRD手术后难治性CME的治疗,YSML治疗可被视为一种安全有效的治疗策略。